EE200100046A - ACAT ja MMP inhibiitorite koosmanustamine aterosklerootiliste kahjustuste raviks - Google Patents
ACAT ja MMP inhibiitorite koosmanustamine aterosklerootiliste kahjustuste raviksInfo
- Publication number
- EE200100046A EE200100046A EEP200100046A EEP200100046A EE200100046A EE 200100046 A EE200100046 A EE 200100046A EE P200100046 A EEP200100046 A EE P200100046A EE P200100046 A EEP200100046 A EE P200100046A EE 200100046 A EE200100046 A EE 200100046A
- Authority
- EE
- Estonia
- Prior art keywords
- acat
- administration
- treatment
- atherosclerotic lesions
- mmp inhibitors
- Prior art date
Links
- 229940124761 MMP inhibitor Drugs 0.000 title 1
- 230000003143 atherosclerotic effect Effects 0.000 title 1
- 238000011260 co-administration Methods 0.000 title 1
- 230000003902 lesion Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9363998P | 1998-07-21 | 1998-07-21 | |
| PCT/US1999/013948 WO2000004892A2 (en) | 1998-07-21 | 1999-06-18 | Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200100046A true EE200100046A (et) | 2002-06-17 |
Family
ID=22239992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100046A EE200100046A (et) | 1998-07-21 | 1999-06-18 | ACAT ja MMP inhibiitorite koosmanustamine aterosklerootiliste kahjustuste raviks |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1098662A2 (is) |
| JP (1) | JP2002521328A (is) |
| KR (1) | KR20010083134A (is) |
| CN (1) | CN1310629A (is) |
| AP (1) | AP2001002035A0 (is) |
| AU (1) | AU4701799A (is) |
| BG (1) | BG105162A (is) |
| BR (1) | BR9912296A (is) |
| CA (1) | CA2335062A1 (is) |
| CZ (1) | CZ2001126A3 (is) |
| EA (1) | EA200100153A1 (is) |
| EE (1) | EE200100046A (is) |
| HR (1) | HRP20010055A2 (is) |
| HU (1) | HUP0102880A3 (is) |
| ID (1) | ID30030A (is) |
| IL (1) | IL140982A0 (is) |
| IS (1) | IS5809A (is) |
| NO (1) | NO20010291L (is) |
| OA (1) | OA11584A (is) |
| PL (1) | PL346011A1 (is) |
| SK (1) | SK502001A3 (is) |
| TR (1) | TR200100205T2 (is) |
| WO (1) | WO2000004892A2 (is) |
| YU (1) | YU3501A (is) |
| ZA (1) | ZA200100294B (is) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001034127A1 (en) * | 1999-11-05 | 2001-05-17 | Warner-Lambert Company | Prevention of plaque rupture by acat inhibitors |
| GT200000203A (es) | 1999-12-01 | 2002-05-24 | Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas. | |
| EP1237862A1 (en) * | 1999-12-17 | 2002-09-11 | Versicor, Inc. | Succinate compounds, compositions and methods of use and preparation |
| MXPA03001857A (es) * | 2000-09-01 | 2003-06-04 | Sankyo Co | Composicones medicinales. |
| GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| CA2479906C (en) * | 2002-04-03 | 2011-02-08 | Topotarget Uk Limited | Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| KR101011373B1 (ko) * | 2002-07-11 | 2011-01-28 | 비큐론 파마슈티컬스 인코포레이티드 | 항균작용을 갖는 ｎ-히드록시아미드 유도체 |
| WO2011092284A1 (en) * | 2010-01-29 | 2011-08-04 | Euroscreen S.A. | Novel amino acid derivatives and their use as gpr43 receptor modulators |
| CN104211695B (zh) * | 2013-06-04 | 2017-04-12 | 中国医学科学院医药生物技术研究所 | 一组胺甲酰基苯磺酰类化合物的用途 |
| WO2016113713A1 (en) * | 2015-01-15 | 2016-07-21 | Biocant - Associação De Transferência De Tecnologia | Treatment of hutchinson-gilford progeria syndrome and diseases related to vascular ageing |
| CN106831697B (zh) * | 2017-03-15 | 2019-11-05 | 深圳市康道生物有限公司 | 川榛有效提取成分及其在防治动脉粥样硬化中的应用 |
| WO2025224168A1 (en) | 2024-04-24 | 2025-10-30 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366987A (en) * | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
| US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| CN1192140A (zh) * | 1995-08-04 | 1998-09-02 | 沃尼尔·朗伯公司 | 氨基磺酸衍生物、酰基磺酰氨或磺酰基氨基甲酸酯在制备降低脂蛋白水平的药物中的用途 |
| NZ332711A (en) * | 1996-05-17 | 2000-06-23 | Warner Lambert Co | Biphenylsulfonylamino carboxylic acid derivatives as matrix metalloproteinase inhibitors |
| BR9711988A (pt) * | 1996-09-04 | 1999-08-24 | Warner Lambert Co | Inibidores de metaloproteinase de matriz e seus empregos terap-uticos |
-
1999
- 1999-06-18 ID IDW20010333A patent/ID30030A/id unknown
- 1999-06-18 CN CN99808958A patent/CN1310629A/zh active Pending
- 1999-06-18 AU AU47017/99A patent/AU4701799A/en not_active Abandoned
- 1999-06-18 CZ CZ2001126A patent/CZ2001126A3/cs unknown
- 1999-06-18 BR BR9912296-0A patent/BR9912296A/pt not_active IP Right Cessation
- 1999-06-18 HU HU0102880A patent/HUP0102880A3/hu unknown
- 1999-06-18 EP EP99930483A patent/EP1098662A2/en not_active Withdrawn
- 1999-06-18 IL IL14098299A patent/IL140982A0/xx unknown
- 1999-06-18 KR KR1020017000930A patent/KR20010083134A/ko not_active Withdrawn
- 1999-06-18 OA OA1200100022A patent/OA11584A/en unknown
- 1999-06-18 SK SK50-2001A patent/SK502001A3/sk unknown
- 1999-06-18 PL PL99346011A patent/PL346011A1/xx unknown
- 1999-06-18 CA CA002335062A patent/CA2335062A1/en not_active Abandoned
- 1999-06-18 YU YU3501A patent/YU3501A/sh unknown
- 1999-06-18 AP APAP/P/2001/002035A patent/AP2001002035A0/en unknown
- 1999-06-18 EE EEP200100046A patent/EE200100046A/xx unknown
- 1999-06-18 HR HR20010055A patent/HRP20010055A2/hr not_active Application Discontinuation
- 1999-06-18 WO PCT/US1999/013948 patent/WO2000004892A2/en not_active Ceased
- 1999-06-18 TR TR2001/00205T patent/TR200100205T2/xx unknown
- 1999-06-18 EA EA200100153A patent/EA200100153A1/ru unknown
- 1999-06-18 JP JP2000560885A patent/JP2002521328A/ja active Pending
-
2001
- 2001-01-10 ZA ZA200100294A patent/ZA200100294B/en unknown
- 2001-01-12 IS IS5809A patent/IS5809A/is unknown
- 2001-01-17 BG BG105162A patent/BG105162A/xx unknown
- 2001-01-18 NO NO20010291A patent/NO20010291L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002521328A (ja) | 2002-07-16 |
| HUP0102880A3 (en) | 2002-11-28 |
| HUP0102880A2 (en) | 2002-06-29 |
| PL346011A1 (en) | 2002-01-14 |
| NO20010291D0 (no) | 2001-01-18 |
| YU3501A (sh) | 2005-06-10 |
| IS5809A (is) | 2001-01-12 |
| IL140982A0 (en) | 2002-02-10 |
| TR200100205T2 (tr) | 2001-05-21 |
| EA200100153A1 (ru) | 2001-08-27 |
| BG105162A (en) | 2001-12-29 |
| CZ2001126A3 (cs) | 2002-01-16 |
| ZA200100294B (en) | 2002-01-10 |
| KR20010083134A (ko) | 2001-08-31 |
| WO2000004892A3 (en) | 2000-05-18 |
| OA11584A (en) | 2004-07-20 |
| EP1098662A2 (en) | 2001-05-16 |
| WO2000004892A2 (en) | 2000-02-03 |
| BR9912296A (pt) | 2001-04-17 |
| HRP20010055A2 (en) | 2002-04-30 |
| NO20010291L (no) | 2001-01-18 |
| ID30030A (id) | 2001-11-01 |
| AP2001002035A0 (en) | 2001-03-31 |
| SK502001A3 (en) | 2002-06-04 |
| AU4701799A (en) | 2000-02-14 |
| CN1310629A (zh) | 2001-08-29 |
| CA2335062A1 (en) | 2000-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2018023I2 (el) | Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης | |
| FI971412L (fi) | Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä | |
| ID22957A (id) | Senyawa dan penggunaannya | |
| EE200100659A (et) | Diaminotiasoolid ja nende kasutamine proteiinikinaaside pärssimiseks | |
| PT977748E (pt) | Derivados benzopirano substituidos para o tratamento de inflamacao | |
| DK1070069T3 (da) | Bicycliske hydroxaminsyrederivater | |
| ID27394A (id) | Kombinasi farmasi yang mengandung inhibitor cox-2 dan inhibitor inos | |
| DE59908110D1 (de) | Cas-erfassbarer endoskop-adapter | |
| ID29591A (id) | Senyawa-senyawa kuinolina dan kuinoksalina | |
| EE200100243A (et) | 5HT1 retseptori agonistid ja metoklopramiid migreeni raviks | |
| NO20001775D0 (no) | Munnhygienepreparat til behandling av halitose | |
| PT1077940E (pt) | 4-fenilpiperidinas novas para o tratamento de dermatoses pruriginosas | |
| PT1206436E (pt) | Retinoides para o tratamento de enfisema | |
| EE200100046A (et) | ACAT ja MMP inhibiitorite koosmanustamine aterosklerootiliste kahjustuste raviks | |
| IT1301973B1 (it) | Idro-fluoroalchilvinileteri e procedimento per il loro ottenimento | |
| IT1302811B1 (it) | Procedimento e relativo apparato per la riduzione direttadi ossidi di ferro | |
| PT1079818E (pt) | Composicao compreendendo il-18 e topotecano para o tratamento e /ou prevencao de cancro | |
| IT1296305B1 (it) | Inibitori di metalloproteinasi loro uso terapeutico e procedimento per la produzione del composto di partenza nella loro | |
| NO20004920D0 (no) | Anvendelse av proteaseinhibitorer for behandling av hudskader | |
| ID28797A (id) | Tioredoksin dan pemrosesan biji-bijian | |
| EE200100084A (xx) | NOS inhibiitorite uued farmatseutilised kasutusv�imalused | |
| EE200300057A (et) | Koostis vähi profülaktikaks ja raviks | |
| PT1200447E (pt) | Oxazinocarbazoles para o tratamento de doencas do snc | |
| NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
| NO20010569D0 (no) | Proteaseinhibitorer for anvendelse ved behandling av psoriasis |